Ameliorative Effects of Lutein Supplementation against Cardio-toxicity Induced by Ciprofloxacin and Daunorubicin: in Rats

        A molecular mechanism of the ciprofloxacin adverse effects provoked thruogh the inhibition of the topoisomerase II in the mitochondrial that cause mitochondrial DNA impairment of transcription and replication. Daunorubicin (DNR) clinical use has been limited by its cardiotoxicity. Iron-medi...

Full description

Saved in:
Bibliographic Details
Main Authors: Alaa R. Khudhair, Nada N. Al-Shawi, Mohammed Abdulameer Oleiwi, Israa Radhi Khudhair Khudhair
Format: Article
Language:English
Published: College of Pharmacy University of Baghdad 2025-06-01
Series:Iraqi Journal of Pharmaceutical Sciences
Online Access:https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/3840
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849430997598208000
author Alaa R. Khudhair
Nada N. Al-Shawi
Mohammed Abdulameer Oleiwi
Israa Radhi Khudhair Khudhair
author_facet Alaa R. Khudhair
Nada N. Al-Shawi
Mohammed Abdulameer Oleiwi
Israa Radhi Khudhair Khudhair
author_sort Alaa R. Khudhair
collection DOAJ
description         A molecular mechanism of the ciprofloxacin adverse effects provoked thruogh the inhibition of the topoisomerase II in the mitochondrial that cause mitochondrial DNA impairment of transcription and replication. Daunorubicin (DNR) clinical use has been limited by its cardiotoxicity. Iron-mediated increase oxidative stress in cardiomyocytes is the main mechanism of the anthracycline cardiotoxicity. Elevated levels of circulating cardiac troponins are myocardial damage predictors. Troponin T and I are cardiac troponins, while troponin C specific to the skeletal muscle. Lutein is an oxygenated carotenoid that derived from the diet in all mammalians including humans. Lutein has anti-inflammatory effects, anti-genotoxic, improving cardiovascular diseases, reducing cancers risk, and improving cognitive functions. This study investigates the cardiotoxicity induced by ciprofloxacin in comparing to the cardiotoxicity of daunorubicin through the measurement of cardiac troponin I, interleukin 6, GSH peroxidase 4 and cleaved caspase-3 levels in heart tissues; and to explore the protective effects of lutein versus the ciprofloxacin and daunorubicin induce cardiotoxicity in the rat. Thirty (30) adult Sprague- Dawley rats of both sexes. Animals are divided to five (5) groups of six (6) rats each: Group Ӏ: given 10% dimethyl sulfoxide for 15 successive days. Group ӀӀ: received Daunorubicin 20 mg/kg for last 3 days with cumulative dose (60 mg/kg) by IP injection. Group III: given for the last 5 days 500 mg/kg ciprofloxacin orally. Group ӀV: received oral dose of lutein (24mg/kg) daily for 15 consecutive days, and Daunorubicin by intraperitoneal injection. Group V: given lutein (24mg/kg) orally daily for 15 days, then given ciprofloxacin oral dose for last 5 days. Cardiotoxicity induced by ciprofloxacin and daunorubicin, associated by increasing levels of cardiac troponin I, interleukin 6, GSH peroxidase 4 and cleaved caspase-3 levels in heart tissues. pretreated cardiotoxic rats with lutein (Group ӀV and Group V) was showed significant decline in the cardiac troponin I level, also reversed oxidative stress markers; rat Glutathione peroxidase 4 levels, to the control level. Suppression of the apoptotic and inflammatory markers, by measuring rat interleukin 6 levels and rat cleaved caspase-3 levels respectively, in heart tissues.
format Article
id doaj-art-db6a7c1eac71499e8adb081159e3fc85
institution Kabale University
issn 1683-3597
2521-3512
language English
publishDate 2025-06-01
publisher College of Pharmacy University of Baghdad
record_format Article
series Iraqi Journal of Pharmaceutical Sciences
spelling doaj-art-db6a7c1eac71499e8adb081159e3fc852025-08-20T03:27:47ZengCollege of Pharmacy University of BaghdadIraqi Journal of Pharmaceutical Sciences1683-35972521-35122025-06-0134210.31351/vol34iss2pp282-288Ameliorative Effects of Lutein Supplementation against Cardio-toxicity Induced by Ciprofloxacin and Daunorubicin: in RatsAlaa R. Khudhair0Nada N. Al-Shawi1Mohammed Abdulameer Oleiwi2Israa Radhi Khudhair Khudhair3Department of Pharmacology and Toxicology, College of Pharmacy, University of Baghdad, Iraq.Department of Pharmacology and Toxicology, College of Pharmacy, University of Baghdad, Iraq.Department of Pharmaceutical Chemistry, College of Pharmacy, University of Baghdad, IraqDepartment of Biology, College of Education of Pure science (Ibn Al-Haitham), University of Baghdad, Iraq.         A molecular mechanism of the ciprofloxacin adverse effects provoked thruogh the inhibition of the topoisomerase II in the mitochondrial that cause mitochondrial DNA impairment of transcription and replication. Daunorubicin (DNR) clinical use has been limited by its cardiotoxicity. Iron-mediated increase oxidative stress in cardiomyocytes is the main mechanism of the anthracycline cardiotoxicity. Elevated levels of circulating cardiac troponins are myocardial damage predictors. Troponin T and I are cardiac troponins, while troponin C specific to the skeletal muscle. Lutein is an oxygenated carotenoid that derived from the diet in all mammalians including humans. Lutein has anti-inflammatory effects, anti-genotoxic, improving cardiovascular diseases, reducing cancers risk, and improving cognitive functions. This study investigates the cardiotoxicity induced by ciprofloxacin in comparing to the cardiotoxicity of daunorubicin through the measurement of cardiac troponin I, interleukin 6, GSH peroxidase 4 and cleaved caspase-3 levels in heart tissues; and to explore the protective effects of lutein versus the ciprofloxacin and daunorubicin induce cardiotoxicity in the rat. Thirty (30) adult Sprague- Dawley rats of both sexes. Animals are divided to five (5) groups of six (6) rats each: Group Ӏ: given 10% dimethyl sulfoxide for 15 successive days. Group ӀӀ: received Daunorubicin 20 mg/kg for last 3 days with cumulative dose (60 mg/kg) by IP injection. Group III: given for the last 5 days 500 mg/kg ciprofloxacin orally. Group ӀV: received oral dose of lutein (24mg/kg) daily for 15 consecutive days, and Daunorubicin by intraperitoneal injection. Group V: given lutein (24mg/kg) orally daily for 15 days, then given ciprofloxacin oral dose for last 5 days. Cardiotoxicity induced by ciprofloxacin and daunorubicin, associated by increasing levels of cardiac troponin I, interleukin 6, GSH peroxidase 4 and cleaved caspase-3 levels in heart tissues. pretreated cardiotoxic rats with lutein (Group ӀV and Group V) was showed significant decline in the cardiac troponin I level, also reversed oxidative stress markers; rat Glutathione peroxidase 4 levels, to the control level. Suppression of the apoptotic and inflammatory markers, by measuring rat interleukin 6 levels and rat cleaved caspase-3 levels respectively, in heart tissues. https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/3840
spellingShingle Alaa R. Khudhair
Nada N. Al-Shawi
Mohammed Abdulameer Oleiwi
Israa Radhi Khudhair Khudhair
Ameliorative Effects of Lutein Supplementation against Cardio-toxicity Induced by Ciprofloxacin and Daunorubicin: in Rats
Iraqi Journal of Pharmaceutical Sciences
title Ameliorative Effects of Lutein Supplementation against Cardio-toxicity Induced by Ciprofloxacin and Daunorubicin: in Rats
title_full Ameliorative Effects of Lutein Supplementation against Cardio-toxicity Induced by Ciprofloxacin and Daunorubicin: in Rats
title_fullStr Ameliorative Effects of Lutein Supplementation against Cardio-toxicity Induced by Ciprofloxacin and Daunorubicin: in Rats
title_full_unstemmed Ameliorative Effects of Lutein Supplementation against Cardio-toxicity Induced by Ciprofloxacin and Daunorubicin: in Rats
title_short Ameliorative Effects of Lutein Supplementation against Cardio-toxicity Induced by Ciprofloxacin and Daunorubicin: in Rats
title_sort ameliorative effects of lutein supplementation against cardio toxicity induced by ciprofloxacin and daunorubicin in rats
url https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/3840
work_keys_str_mv AT alaarkhudhair ameliorativeeffectsofluteinsupplementationagainstcardiotoxicityinducedbyciprofloxacinanddaunorubicininrats
AT nadanalshawi ameliorativeeffectsofluteinsupplementationagainstcardiotoxicityinducedbyciprofloxacinanddaunorubicininrats
AT mohammedabdulameeroleiwi ameliorativeeffectsofluteinsupplementationagainstcardiotoxicityinducedbyciprofloxacinanddaunorubicininrats
AT israaradhikhudhairkhudhair ameliorativeeffectsofluteinsupplementationagainstcardiotoxicityinducedbyciprofloxacinanddaunorubicininrats